Current Studies

Current Studies

  • Autism Biorepository
    The purpose of this study is to determine genetic factors that influence the development of autism.
  • The aV1ation Study
    The purpose of this study is to test an investigational medicine that blocks a hormone receptor in the brain linked to the control of socialization, stress, anxiety, and aggression.
  • The FX-LEARN Study
    The purpose of this study is to find out if the drug AFQ056, made by the pharmaceutical company Novartis, is safe and has beneficial effects on language learning in children who have Fragile-X syndrome (FXS). The study also aims to find out if a structured language intervention can help children with Fragile-X syndrome communicate better.